Aoki Y - Search Results

1

Paclitaxel in combination with cisplatin is less effective for peripheral blood progenitor cell mobilization.

Kurata H, Takakuwa K, Tsuneki I, Aoki Y, Tanaka K. Kurata H, et al. Among authors: aoki y. Int J Gynecol Cancer. 2000 Nov;10(6):459-462. doi: 10.1046/j.1525-1438.2000.00075.x. Int J Gynecol Cancer. 2000. PMID: 11240715

2

Palmar fasciitis and polyarthritis associated with squamous cell carcinoma of the cervix.

Kase H, Aoki Y, Sugaya S, Takakuwa K, Tanaka K. Kase H, et al. Among authors: aoki y. Int J Gynecol Cancer. 2000 Nov;10(6):507-509. doi: 10.1046/j.1525-1438.2000.00078.x. Int J Gynecol Cancer. 2000. PMID: 11240722

3

Circulating CD34+ cells to predict the adequate harvest of peripheral blood progenitor cells in platinum-based chemotherapy.

Kurata H, Takakuwa K, Tsuneki I, Aoki Y, Tanaka K. Kurata H, et al. Among authors: aoki y. Arch Gynecol Obstet. 2002 Jan;266(1):34-7. doi: 10.1007/pl00007496. Arch Gynecol Obstet. 2002. PMID: 11998962

4

Docetaxel in combination with carboplatin for chemo-naive patients with epithelial ovarian cancer.

Aoki Y, Sato T, Tsuneki I, Watanabe M, Kase H, Fujita K, Kurata H, Tanaka K. Aoki Y, et al. Int J Gynecol Cancer. 2002 Nov-Dec;12(6):704-9. doi: 10.1046/j.1525-1438.2002.01118.x. Int J Gynecol Cancer. 2002. PMID: 12445246 Clinical Trial.

5

Circulating highly fluorescent reticulocytes to predict the adequate harvesting of peripheral blood progenitor cells in platinum-based chemotherapy.

Kurata H, Takakuwa K, Tsuneki I, Aoki Y, Tanaka K. Kurata H, et al. Among authors: aoki y. Transfus Apher Sci. 2002 Dec;27(3):199-202. doi: 10.1016/s1473-0502(02)00065-4. Transfus Apher Sci. 2002. PMID: 12509213

6

Failure of high-dose chemotherapy with peripheral blood stem cell support for refractory placental site trophoblastic tumor.

Aoki Y, Kodama S, Kurata H, Kase H, Tanaka K. Aoki Y, et al. Gynecol Obstet Invest. 1999;47(3):214-6. doi: 10.1159/000010081. Gynecol Obstet Invest. 1999. PMID: 10087421

7

Analysis of TH1 and TH2 cells by intracellular cytokine detection with flow cytometry in patients with ovarian cancer.

Aoki Y, Tsuneki I, Sasaki M, Watanabe M, Sato T, Aida H, Tanaka K. Aoki Y, et al. Gynecol Obstet Invest. 2000;50(3):207-11. doi: 10.1159/000010312. Gynecol Obstet Invest. 2000. PMID: 11014957

8

Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.

Aoki Y, Sato T, Watanabe M, Sasaki M, Tsuneki I, Tanaka K. Aoki Y, et al. Gynecol Oncol. 2001 Jun;81(3):496-9. doi: 10.1006/gyno.2001.6195. Gynecol Oncol. 2001. PMID: 11371145 Clinical Trial.

9

Pharmacokinetics of paclitaxel and cisplatin in a hemodialysis patient with recurrent ovarian cancer.

Tomita M, Kurata H, Aoki Y, Tanaka K, Kazama JJ. Tomita M, et al. Among authors: aoki y. Anticancer Drugs. 2001 Jun;12(5):485-7. doi: 10.1097/00001813-200106000-00010. Anticancer Drugs. 2001. PMID: 11395577

10

Low risk endometrial cancer: a study of pelvic lymph node metastasis.

Watanabe M, Aoki Y, Kase H, Fujita K, Tanaka K. Watanabe M, et al. Among authors: aoki y. Int J Gynecol Cancer. 2003 Jan-Feb;13(1):38-41. doi: 10.1046/j.1525-1438.2003.13037.x. Int J Gynecol Cancer. 2003. PMID: 12631218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,562 results

Search Page

Filters